statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Radar: Power Grid, Nykaa, Gland Pharma, Go Digit, Granules India in focus on Thursday

ITC, InterGlobe Aviation, Honasa Consumer, Bayer Cropscience, Cello World, CESC, Concord Biotech, Finolex Cables, Page Industries, Tata Investment Corporation, and Zaggle Prepaid Ocean Services will release March quarter earnings on May 23.

Trade Spotlight | How to trade in Cummins India, BEML, Gland Pharma counters today

Cummins India has been a big star performer in the past several months and maintained higher highs, higher lows formation. The stock has seen formation of bullish candlestick pattern on the daily charts, with above average volumes.

Gland Pharma shares rise 4% as firm receives US FDA nod for cancer shot

Plerixafor Injection is used by patients with certain types of cancer to prepare them for stem cell transplant

Gland Pharma gets FDA nod for Cetrorelix Acetate for injection but stock down

Gland Pharma expects to launch the product in the near-term through its marketing partner

Bulk deals: Promoter entity offloads stake in Gland Pharma

Nicomac Machinery Private Ltd, an entity connected to the former promoter of the company Dr Ravi Penmetsa, sold its entire 19.55 lakh shares, a 1.19 percent stake at an average price of Rs 1735.31.

Block deal in Gland Pharma as ex-promoter offloads stake worth Rs 1,590 crore

Nicomac Machinery Private Ltd and RP Advisory Services Private Ltd, the two entities linked to the former promoter of Gland Pharma, were looking to unload a 4.4 percent stake in the drug manufacturer

Gland Pharma's ex-promoter Dr Ravi Penmetsa launches $150-mn block deal with upsize option

The floor price, which is at a discount of 7.3 percent, is likely to be at Rs 1,725 per share

Gland Pharma shares up nearly 2% on USFDA approval for Eribulin Mesylate injection

Gland Pharma Share Price: The share price has gained 70 percent over the last 9 months.

Buy Gland Pharma; target of Rs 2240: Motilal Oswal

Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 2240 in its research report dated March 20, 2024.

Gland Pharma Q3 results: Net profit down 17%, revenue up 65%

Gland Pharma's revenue came in at Rs 1,545.2  crore, up 65 percent from the year-ago quarter

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. The company was founded by P. V. N. Raju in 1978 and is headquartered in Sangareddy, India.

Volume	127,144.00
52-Wk High	2,194.00
52-Wk Low	1,265.65

GLAND.NSE Gland Pharma Ltd.

About

Feed

News

Sentiment

Fundamentals